Replies to post #13635 on Momenta Pharmaceuticals, Inc. (MNTA)

[DFRAI]

This offering basically replaces the 2nd ATM

The shares are spoken for and it removes uncertainty going solely thru Stifel in my opinion

[jbog]

Wow,

Another $160 mil in the bank. I'm guessing the ATM is also on so it seems that unless they want to buy something they have no intention of making any money off of Copaxone for a long time.

Maybe Dew could remind me why this isn't massive dilution again.

Absolutely the worse management I've ever seen.

[DewDiligence]

MNTA diluted share count for valuation purposes:

At 6/30/15, MNTA had 68.8M basic shares issued (http://www.sec.gov/Archives/edgar/data/1235010/000110465915055823/a15-11889_110q.htm#CONDENSEDCONSOLIDATEDBALANCESHEE_065610 ).

In the 5/19/15 SEC filing for the public offering (http://www.sec.gov/Archives/edgar/data/1235010/000104746915004924/a2224849z424b5.htm ), MNTA disclosed 7.9M options issued at an average exercise price of $14.25. Inasmuch as MNTA is trading near the highest price in effect during the period in which these options were granted, I make the conservative decision to include all of the 7.9M options in my tally.

Therefore, my diluted share count for valuation purposes is 76.7M.

(I do not use the “treasury method” of calculating the diluted share count, which reduces the share count according to the price at which options are exercisable, because the straightforward method of counting all options without adjustment gives a more realistic view of the number of shares that would need to be cashed out in a buyout at a typical premium.)